Toll-like receptor (TLR) signaling activates dendritic cells (DC) to secrete proin¯ammatory cytokines and up-regulate co-stimulatory molecule expression, thereby linking innate and adaptive immunity. A TLR-associated adapter protein, MyD88, is essential for cytokine production induced by TLR. However, in response to a TLR4 ligand, lipopolysaccharide (LPS), MyD88-de®cient (MyD88 ±/± ) DC can up-regulate co-stimulatory molecule expression and enhance their T cell stimulatory activity, indicating that the MyD88-independent pathway through TLR4 can induce some features of DC maturation. In this study, we have further characterized function of LPS-stimulated, MyD88 ±/± DC. In response to LPS, wild-type DC could enhance their ability to induce IFN-g production in allogeneic mixed lymphocyte reaction (alloMLR). In contrast, in response to LPS, MyD88 ±/± DC augmented their ability to induce IL-4 instead of IFN-g in alloMLR. Impaired production of T h 1-inducing cytokines in MyD88 ±/± DC cannot fully account for their increased T h 2 cell-supporting ability, because absence of T h 1-inducing cytokines in DC caused impairment of IFN-g, but did not lead to augmentation of IL-4 production in alloMLR. In vivo experiments with adjuvants also revealed T h 2-skewed immune responses in MyD88 ±/± mice. These results demonstrate that the MyD88-independent pathway through TLR4 can confer on DC the ability to support T h 2 immune responses.
Introduction
Toll-like receptors (TLR) are type I transmembrane proteins expressed on antigen-presenting cells (APC) including macrophages and dendritic cells (DC), and play critical roles in recognizing microbial components called as pathogen-associated molecular patterns (1,2). For example, TLR4 and TLR9 are essential for recognizing lipopolysaccharide (LPS) from Gram-negative bacteria and bacterial DNA containing CpG motifs respectively (3±5). Upon recognition of these TLR ligands, TLR can induce cytokine production and up-regulation of co-stimulatory molecule expression in APC, thereby conferring on APC the ability to activate adaptive immune responses.
A cytoplasmic adapter protein, MyD88, associates with TLR and is essential for cytokine production in response to TLR ligands including LPS (6±9). However, in response to LPS, MyD88 ±/± DC can up-regulate surface expression of costimulatory molecules and T cell stimulatory activity, indicating that TLR4 signaling can lead to DC maturation in a MyD88-independent manner (10) . However, it remains unknown whether MyD88 ±/± DC are functionally equivalent to wild-type DC.
In this study, we have further characterized T cell stimulatory activity of MyD88 ±/± DC. LPS could augment the ability of wildtype DC to support T h 1 cell differentiation in allogeneic mixed lymphocyte reaction (alloMLR). However, LPS could enhance T h 2 cell-supporting ability of MyD88 ±/± DC. This ability did not depend only on defective production of T h 1-inducing cytokines such as IL-12 in MyD88 ±/± DC. These results strongly suggest that TLR4 signaling can induce MyD88 ±/± DC to support T h 2 cell differentiation through as yet unidenti®ed mechanism.
Methods

Mice
C57BL/6 or BALB/c mice were purchased from SLC (Shizuoka, Japan). TLR4 ±/± (11), MyD88 ±/± (12) and IL-18 ±/± (13) mice were generated as described previously. IL-12 ±/± mice were generously provided by Dr J. Magram (14) . IL-12 ±/± mice were crossed with IL-18 ±/± mice to generate mice heterozygous for the IL-12 and IL-18 genes. These mice were intercrossed to create mice lacking both IL-12 and IL-18 (IL-12/18 ±/± mice). MyD88 ±/± mice were backcrossed to C57BL/6 or BALB/c mice >6 times. IL-12 ±/± , IL-18 ±/± and IL-12/18 ±/± mice were backcrossed to C57BL/6 mice >6 times. TLR4 ±/± mice were backcrossed to C57BL/6 mice twice.
Generation of bone marrow (BM)-derived DC
BM DC were generated as described previously (15) . Brie¯y, BM cells were obtained from wild-type (C57BL/6) or mutant mice and plated at 1 Q 10 6 cells/ml in 24-well plates with 10% FCS/RPMI 1640 with 10 ng/ml murine granulocyte macrophage colony stimulating factor (GM-CSF; Genzyme TECHNE, Minneapolis, MN). Every 2 days, non-adherent cells were discarded and the remaining cells were fed with fresh medium containing 10 ng/ml murine GM-CSF. At day 6, loosely adherent cells were harvested by gentle pipeting and cultured with or without 100 ng/ml LPS (derived from Escherichia coli O55:B5; Sigma, St Louis, MO) for a further 48 h.
AlloMLR assay
AlloMLR assay was performed as described previously (10) . Brie¯y, unstimulated or LPS-stimulated BM DC (at day 8) were irradiated and co-cultured with 0.5±1 Q 10 5 /well of splenic CD4 + T cells from BALB/c background mice. CD4 + T cells were puri®ed by utilizing MACS with CD4 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). For measuring T cell proliferation, cultures were performed for 3 days and [ 3 H]thymidine was added for the last 15 h. For measuring cytokines, culture supernatants were harvested after 4-day coculture. Amounts of IL-12 p40, IFN-g and IL-4 were measured with ELISA kits (Genzyme TECHNE). In some experiments, cocultures were performed at indicated concentrations of IL-12. IL-12 was kindly provided by Dr H. Tsutsui (Hyogo Medical College, Hyogo, Japan).
Flow cytometry
Cells were ®rst incubated with anti-CD16/32 (2.4G2; BD Biosciences, Mountain View, CA) to block non-speci®c binding of antibodies to FcR. They were further stained with biotinylated anti-CD40 mAb (3/23; BD Biosciences) for 20 min at 4°C, washed and subsequently developed with streptavidin±phycoerythrin (BD Biosciences). Flow cytometric analysis was performed using a FACSCalibur (BD Biosciences) with CellQuest software (BD Biosciences).
Immunization with keyhole limpet hemocyanin (KLH)
KLH (Calbiochem, San Diego, CA) was emulsi®ed with complete Freund's adjuvant (CFA) (Iatron, Tokyo, Japan) before injection and 100 mg/head of KLH±CFA was injected into hind footpads. Nine days later, bilateral popliteal and inguinal lymph node cells were harvested and CD4 + cells were puri®ed by utilizing MACS with CD4 microbeads. For measuring T cell proliferation, 1 Q 10 5 CD4 + cells were co-cultured with 1 Q 10 5 irradiated C57BL/6 splenocytes at various concentrations of KLH for 3 days. 
Results
LPS-stimulated MyD88 ±/± DC support T h 2 cell differentiation
In order to evaluate the function of LPS-stimulated BM DC, we have investigated cytokine production from alloMLR ( Fig. 1) . Wild-type, TLR4 ±/± or MyD88 ±/± BM DC at day 6 were untreated or treated with LPS for further 48 h, irradiated and then cocultured with allogeneic CD4 + T cells derived from BALB/c mice. LPS treatment augmented IFN-g production, but inhibited IL-4 production from alloMLR of wild-type DC. In contrast, LPS-stimulated MyD88 ±/± DC did not show enhancement of IFN-g production, but exhibited signi®cant elevation of IL-4 production from their alloMLR. Thus, in response to LPS, wild-type and MyD88 ±/± DC enhanced their T h 1 and T h 2 cellsupporting ability, respectively. LPS treatment did not modulate either IFN-g or IL-4 production from alloMLR of TLR4 ±/± DC, verifying that LPS-induced effects depend on TLR4.
We have next tested whether MyD88 in T cells is also critical for T h cell differentiation (Fig. 2) . To assess this, wild-type or MyD88 ±/± DC were co-cultured with CD4 + T cells from Fig. 1 . LPS enhances the ability of wild-type and MyD88 ±/± BM DC to support T h 1 and T h 2 cell differentiation respectively. Wild-type, TLR4 ±/± or MyD88 ±/± BM DC at day6 were untreated (med) or stimulated with LPS for 48 h, irradiated, plated at 1 Q 10 4 /well and co-cultured with allogeneic BALB/c CD4 + T cells for a further 4 days. IFN-g and IL-4 production in supernatants of alloMLR was measured by ELISA. The data indicate means T SD of triplicate samples of one representative experiment.
MyD88 ±/± mice with a BALB/c background. In response to LPS, both wild-type and MyD88 ±/± DC showed enhanced ability to support proliferation of MyD88 ±/± CD4 + T cells ( Fig. 2A) . LPSstimulated wild-type DC induced augmentation of IFN-g production when co-cultured with MyD88 ±/± CD4 + T cells (Fig. 2B) . Furthermore, LPS conferred on MyD88 ±/± DC the ability to augment IL-4 production from their co-culture with MyD88 ±/± CD4 + T cells. Thus, MyD88 ±/± CD4 + T cells can differentiate into T h 1 or T h 2 cells in a similar manner to wildtype CD4 + T cells (Fig. 1) when co-cultured with LPSstimulated wild-type or MyD88 ±/± DC. These results suggest that MyD88 in DC, but not in T cells, is critical for decision of T h cell differentiation pathway.
Impaired IL-12 production in alloMLR of LPS-stimulated MyD88 ±/± DC IL-12 is produced by APC and act on T cells as a potent activator for T h 1 cell differentiation (16) . LPS-induced induction of IL-12 is abolished in MyD88 ±/± macrophages and DC (10, 17) . Therefore, we have investigated IL-12 production also from alloMLR. LPS treatment could enhance the ability of wildtype DC to produce IL-12 from alloMLR (Fig. 3A) . However, IL-12 production was severely impaired in alloMLR of both TLR4 ±/± and MyD88 ±/± DC (Fig. 3A) . We have next investigated effects of exogenous IL-12 on alloMLR of LPS-stimulated MyD88 ±/± DC (Fig. 3B) . Exogenous IL-12 signi®cantly enhanced IFN-g production from alloMLR of LPS-stimulated MyD88 ±/± DC (Fig. 3B) . However, IL-12 could not inhibit IL-4 production from alloMLR of LPS-stimulated MyD88 ±/± DC (Fig. 3B ).
T h cell-supporting ability of DC lacking T h 1-inducing cytokines
In addition to IL-12, IL-18 can also stimulate T and NK cells to produce IFN-g (18, 19) . Notably, IL-12 and IL-18 can synergistically enhance IFN-g production. Therefore, although IL-18 concentration in alloMLR of LPS-stimulated wild-type DC was <10 pg/ml (data not shown), we have analyzed the function of IL-12 ±/± , IL-18 ±/± and IL-12/18 ±/± DC (Fig. 4) . In response to LPS, all mutant DC showed up-regulation of CD40 expression at comparable levels with wild-type DC (Fig. 4A) . Furthermore, LPS could augment the ability of not only wild-type, but also all mutant DC to support allogeneic T cell proliferation (Fig. 4B) .
Next, T h cell-supporting ability of DC was analyzed (Fig. 4C) . LPS treatment could enhance the ability of IL-12 ±/± and IL-18 ±/± DC to produce IFN-g from their alloMLR. However, mutant DC lacking both cytokines did not augment their ability to induce IFN-g production in response to LPS. Thus, the results indicate that T h 1 cell-supporting ability of LPS-stimulated DC requires either IL-12 or IL-18. However, IL-4 production from alloMLR of all LPS-stimulated DC including IL-12/18 ±/± DC was not elevated, but suppressed. Taken together, although defective production of T h 1-promoting cytokines, IL-12 and IL-18, in DC can cause impaired IFN-g production from alloMLR, it alone cannot result in enhanced IL-4 production as observed in alloMLR of LPS-stimulated MyD88 ±/± BM DC.
T h 2-deviated immune responses of MyD88 ±/± mice
We have next tested whether MyD88 is critical for T h 1/T h 2 balance in vivo. KLH emulsi®ed with CFA was s.c. injected into footpads of wild-type, TLR4 ±/± and MyD88 ±/± mice. Nine days after immunization, CD4 + T cells were prepared from draining lymph nodes and their responses to KLH were evaluated (Fig. 5) . CD4 + T cells from immunized wild-type mice showed KLH-dependent proliferative responses. They also produced IFN-g in an KLH dose-dependent manner. However, CD4 + T cells from immunized MyD88 ±/± mice showed impaired proliferation and decreased production of IFN-g in response to KLH.
In contrast, their IL-4 production was prominently enhanced compared with CD4 + T cells from immunized control mice. TLR4 ±/± CD4 + T cells also showed impairment of antigendependent proliferative responses, which were concomitant with diminished production of both IFN-g and IL-4. Taken together, not only in vitro, but also in vivo TLR4 signaling can induce augmented T h 2 cell differentiation in the absence of MyD88.
Discussion
Accumulating lines of evidence indicates that T cell differentiation into T h 1 or T h 2 is regulated not only by T cells themselves but also by DC (20, 21) . First, maturation stimuli DC receive regulate DC function. For example, TLR ligands such as E. coli LPS can stimulate the ability of DC to support T h 1 cell differentiation, while certain microbial products including a soluble extract of the helminth eggs can enhance T h 2 cell-supporting ability of DC (22±24). Second, DC activation status is also important, because DC can prime T h 1 responses soon after stimulation, but the same cells can prime T h 2 responses at later time points (25) . Furthermore, the T h cell-supporting ability also depends on DC subsets (26, 27) . However, the molecular mechanism involved in the T h cellsupporting ability of DC still remains largely unknown. In this study we have analyzed the function of LPS-stimulated, MyD88 ±/± DC. In response to LPS, wild-type DC augmented T h 1 cell-supporting ability, whereas MyD88 ±/± DC lacked T h 1, but enhanced instead T h 2 cell-supporting ability. The results indicate that MyD88 is a critical adaptor for regulating T h 1/T h 2 balance.
MyD88 ±/± DC lack the ability to produce a T h 1-inducing cytokine, IL-12, in response to LPS (8, 10) . AlloMLR of LPSstimulated, MyD88 ±/± DC also showed impaired production of IL-12 (Fig. 3) . Therefore, it is possible that the T h 2 cellsupporting ability of MyD88 ±/± DC is due to defective production of T h 1-inducing cytokines. However, this possibility seems unlikely. First, exogenous IL-12 could augment IFN-g, but could not inhibit IL-4 production from alloMLR of LPS-stimulated, MyD88 ±/± DC. Furthermore, analysis of mutant DC lacking T h 1-inducing cytokines, IL-12 and IL-18, also argues against this possibility. While T h 1 cell-supporting ability of LPS-stimulated IL-12/18 ±/± DC was abolished, their T h 2 cellsupporting ability was not augmented. Proliferative response of allogeneic T cells co-cultured with IL-12/18 ±/± DC was comparable with that of those co-cultured with wild-type DC (Fig. 4B) , excluding the possibility that failure to support T h 2 cell differentiation is not due to diminished proliferation of T cells. These results demonstrate that either IL-12 or IL-18 is required for generating T h 1 cell-supporting ability of DC, but also indicate that defective production of T h 1-inducing cytokines alone cannot fully account for T h 2 skewing ability of LPS-stimulated MyD88 ±/± DC.
IL-18 can induce IL-4 production from T cells in the absence of IL-12 (28) . Furthermore, LPS-induced IL-18 secretion is independent of MyD88 in liver macrophages (29) . These facts suggest the possibility that IL-18 produced by MyD88 ±/± DC induce allogeneic T cells to differentiate into T h 2 cells. IL-18 plays a signi®cant role in IFN-g production from alloMLR, which was revealed when alloMLR of IL-12 ±/± DC was compared with that of IL-12/IL-18 ±/± DC (Fig. 4) . However, it is unlikely that IL-18 is involved in IL-4 production from alloMLR of LPSstimulated MyD88 ±/± DC. First, alloMLR of LPS-stimulated DC lacking IL-12 did not show increased production of IL-4 (Fig. 4C) . Importantly, allogeneic T cells lacking MyD88, which is essential for IL-18 signaling (12), still augmented their IL-4 production co-cultured with MyD88 ±/± DC treated with LPS (Fig. 2) . These results strongly suggest that IL-18 is not involved in enhanced production of IL-4 in alloMLR of LPSstimulated, MyD88 ±/± DC.
Schnare et al. have also shown that MyD88 de®ciency can cause defective T h 1 immune responses (30) . Because MyD88 ±/± T cells retained the ability to differentiate into T h 1 or T h 2 cells, they also argue that MyD88 plays critical roles in APC. The adjuvant they used could not up-regulate costimulatory molecule expression on MyD88 ±/± DC (30) . The adjuvant, CFA, contains killed mycobacteria extract, which is rich in TLR2 and TLR4 ligands. All effects through TLR2 signaling are dependent on MyD88, while TLR4 signaling can induce maturation of MyD88 ±/± DC (10). Therefore, it can be assumed that their adjuvant contains TLR2 ligands much more abundantly than TLR4 ligands. In this context, impaired immune responses in their study can be ascribed to abrogated maturation of MyD88 ±/± DC. In the present study, TLR4 ±/± mice exhibited impaired immune responses to KLH±CFA (Fig. 5) , indicating that our adjuvant contains large amounts of TLR4 ligands. As shown in this study, TLR4 signaling can make MyD88 ±/± DC differentiate into T h 2-inducing DC in vitro. Therefore, DC activated through TLR4 can likely contribute to T h 2-skewed immune responses in MyD88 ±/± mice (Fig. 5) .
At present, it remains unknown how TLR4 signaling can actively instruct MyD88 ±/± DC to support T h 2 cell differentiation. Several genes including IFN-inducible ones such as a member of CXC chemokine, IFN-g-inducible chemokine, IP-10, have been found to be TLR4 dependent, but MyD88 independent (17) . However, none of these molecules can fully account for the T h 2 cell-supporting ability of MyD88 ±/± DC. Another TLR4-associating molecule, TIRAP/MAL, is likely involved in expression of such T h 2 cell-supporting molecule(s) (31, 32) . It should be important to clarify the signaling pathway downstream of TIRAP/MAL.
LPS can instruct MyD88-expressing DC to support T h 1-inducing ability, indicating that the MyD88-dependent pathway is predominant over the MyD88-independent one in wildtype DC. However, in the absence of MyD88, the MyD88-independent pathway makes DC competent to support T h 2 cell differentiation. It remains unknown whether MyD88 expression in DC decreases in response to certain stimuli or whether there exist DC subsets lacking MyD88. In any cases, the balance between MyD88-dependent and -independent pathway in DC should be critical for determining the quality of T h cell responses. 
